Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in Refractory Nasal Polyps
NCT05405478Phase 4Unknown
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2022
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in nasal polyps, sponsored by Shiraz University of Medical Sciences. Status: unknown.
02
Drugs
omalizumab
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT05405478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05405478.